We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Zogenix Painkiller Despite Advisory Panel’s Objections
FDA Approves Zogenix Painkiller Despite Advisory Panel’s Objections
October 25, 2013
The FDA Oct. 25 approved Zogenix’s opioid painkiller Zohydro ER in a decision that strayed from an agency advisory panel’s overwhelming recommendation against the drug’s approval due to its “high potential for abuse.”